Targeting urothelial cancer by inhibiting drug transporter of tumor blood vessels
Project/Area Number |
17K11116
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Multi-year Fund |
Section | 一般 |
Research Field |
Urology
|
Research Institution | Hokkaido University |
Principal Investigator |
|
Co-Investigator(Kenkyū-buntansha) |
菊地 奈湖 (間石奈湖) 北海道大学, 歯学研究院, 助教 (00632423)
樋田 泰浩 北海道大学, 大学病院, 准教授 (30399919)
大澤 崇宏 北海道大学, 大学病院, 助教 (60374443)
|
Project Period (FY) |
2017-04-01 – 2020-03-31
|
Project Status |
Completed (Fiscal Year 2019)
|
Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2019: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
|
Keywords | 薬剤耐性 / 腫瘍血管内皮 / 尿路上皮がん / P-glycoprotein / IL-8 / 薬物耐性 / 腫瘍血管 / 尿路上皮癌 / トランスポーター / 血管新生 |
Outline of Final Research Achievements |
P-glycoprotein (P-gp), ATP binding cassette transporter, causes drug resistance. We have reported that tumor endothelial cells (TECs) are resistant to paclitaxel (PTX) with P-gp upregulation. PTX is often selected in salvage chemotherapy for urothelial carcinoma (UC), however its outcomes are limited. We hypothesized that TEC P-gp is the cause of this situation. We demonstrated that the number of P-gp positive TECs increased after chemotherapy in UC. High P-gp expression in TECs was correlated with poor prognosis in patients with UC. As the mechanism, chemotherapy elevated P-gp expression in ECs via increasing tumor IL-8 secretion. When the P-gp inhibitor was combined with PTX, tumor growth and metastasis were more reduced with anti-angiogenic effect compared to PTX alone. It was suggested that chemotherapy causes inflammatory changes in tumors, which induce P-gp expression in TECs and cause drug resistance. Targeting P-gp in TECs can be a novel strategy to overcome drug resistance.
|
Academic Significance and Societal Importance of the Research Achievements |
抗癌剤により腫瘍細胞の性質変化がおこることはよく知られているが、腫瘍間質細胞の一つである腫瘍血管内皮細胞も性質変化を起こしていることは新たな発見である。その性質変化の一つである腫瘍血管内皮細胞の薬剤トランスポーター発現上昇が尿路上皮癌の予後不良因子であることがわかり、薬剤耐性克服の治療戦略として腫瘍血管内皮細胞の薬剤トランスポーターを標的とする必要があることが証明された。 さらに薬剤トランスポーターの発現が上昇するメカニズムとして腫瘍細胞由来のIL-8が関与していることがわかった。本研究は薬剤耐性克服のために標的とすべき分子が同定され、新たな治療法開発につながる研究である。
|
Report
(4 results)
Research Products
(41 results)
-
[Journal Article] Carbonic anhydrase 2 (CAII) supports tumor blood endothelial cell survival under lactic acidosis in the tumor microenvironment2019
Author(s)
Dorcas Akuba Muhyia Annan, Nako Maishi, Tomoyoshi Soga, Randa Dawood, Cong Li, Hiroshi Kikuchi, Takayuki Hojo, Masahiro Morimoto, Tetsuya Kitamura, Mohammad Towfik Alam, Kazuyuki Minowa, Nobuo Shinohara, Jin-Min Nam, Yasuhiro Hida, Kyoko Hida
-
Journal Title
Cell Communication and Signaling
Volume: 17
Issue: 1
Pages: 169-169
DOI
Related Report
Peer Reviewed / Open Access / Int'l Joint Research
-
[Journal Article] Development of immortalized human tumor endothelial cells from renal cancer2019
Author(s)
Nako Maishi, Hiroshi Kikuchi, Masumi Sato, Hiroko Nagao-Kitamoto, Dorcas A. Annan, Shogo Baba, Takayuki Hojo, Misa Yanagiya, Yusuke Ohba, Genichiro Ishii, Kenkichi Masutomi, Nobuo Shinohara, Yasuhiro Hida, Kyoko Hida
-
Journal Title
Int J Mol Sci
Volume: 20
Issue: 18
Pages: 4595-4595
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Journal Article] Vasohibin-1 as a novel prognostic factor for head and neck squamous cell carcinoma2017
Author(s)
Torii C., Hida Y., Shindoh M., Akiyama K., Ohga N., Maishi N., Ohiro Y., Ono M., Totsuka Y., Kitagawa Y., Tei K., Sato Y., Hida K.
-
Journal Title
Anticancer Res
Volume: 37
Issue: 3
Pages: 1219-1225
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Presentation] Biglycan, tumor endothelial cell secreting proteoglycan, as possible biomarker for lung cancer2018
Author(s)
Hida Y., Morimoto H., Maishi N., Nishihara H., Hatanaka Y., Matsuno Y., Nakamura T., Hirano S., Hida K.
Organizer
20th International Vascular Biology Meeting
Related Report
Int'l Joint Research
-
-
[Presentation] Biglycan, tumor endothelial secreting proteoglycan, as possible biomarker for lung cancer2018
Author(s)
Morimoto H., Maishi N., Hida Y., Nishihara H., Hatanaka Y., Matsuo Y., Nakamura Y., Hirano S., Hida K.
Organizer
AACR ANNUAL MEETING 2018
Related Report
Int'l Joint Research
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
[Presentation] Analysis of multidrug resistant transporter expression in tumor blood vessels of urothelial carcinoma during chemotherapy2017
Author(s)
4.Kikuchi H., Maishi N., Akiyama K., Morimoto M., Yanagiya M., Miyajima N., Tsuchiya K., Maruyama S., Abe T., Hida Y., Harabayashi T., Ameda K., Matsumoto R., Kashiwagi A., Matsuno Y., Shinohara N., Hida K.
Organizer
ASCO Annual Meeting
Related Report
Int'l Joint Research
-
[Presentation] 尿路上皮癌における抗癌剤治療後の腫瘍血管ABCB1発現亢進2017
Author(s)
6.菊地 央, 間石奈湖, 秋山廣輔, 森本真弘, 土屋邦彦, 丸山 覚, 安部崇重, 樋田 泰浩, 原林 透, 飴田 要, 松本隆児, 柏木 明, 松野吉宏, 篠原信雄, 樋田京子
Organizer
第26回日本がん転移学会学術集会
Related Report
-
[Presentation] Analysis of multidrug resistant transporter expression in tumor blood vessels of urothelial carcinoma during chemotherapy2017
Author(s)
7.菊地 央, 間石奈湖, 秋山廣輔, Randa Ibrahim Hassan Dawood, 土屋邦彦, 丸山 覚, 安部崇重, 樋田泰浩,原林 透, 飴田 要, 柏木 明, 松野吉宏, 篠原信雄, 樋田京子
Organizer
第5回がんと代謝研究会 in 札幌
Related Report